Treatment of Postpartum Hemorrhage with Blood Products in a Tertiary Hospital: Outcomes and Predictive Factors Associated with Severe Hemorrhage

Clinical and Applied Thrombosis/Hemostasis

Volumn 22, Issue 7, 2016, Pages 685-692

  Guasch, Emilia ^a   Gilsanz, Fernando ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

bleeding; blood coagulation factors; gynecology and obstetrics

Indexed keywords

CREATININE; FIBRINOGEN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; TROPONIN I;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ACUTE LIVER FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CLINICAL FEATURE; COMORBIDITY; ELECTROCARDIOGRAPHY; FEMALE; FETUS DISTRESS; HEART MUSCLE ISCHEMIA; HEMOSTASIS; HUMAN; LUNG EDEMA; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE COMPLICATION; POSTPARTUM HEMORRHAGE; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TERTIARY CARE CENTER; THROMBOCYTE TRANSFUSION; URINARY TRACT INJURY; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; POSTPARTUM HEMORRHAGE; RETROSPECTIVE STUDIES; RISK FACTORS; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 84984870827     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029615573303     Document Type: Article

References (28)

1. Gayat E, Resche-Rigon M, Morel O, et al. Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study. Intensive Care Med. 2011; 37 (11): 1816-1825.
2. Zeeman GG,. Obstetric critical care: a blueprint for improved outcomes. Crit Care Med. 2006; 34 (9 suppl): S208-S214.
3. Zhang WH, Alexander S, Bouvier-Colle MH, et al. Incidence of severe pre-eclampsia, postpartum haemorrhage and sepsis as a surrogate marker for severe maternal morbidity in a European population-based study: the MOMS-B survey. BJOG. 2005; 112 (1): 89-96.
4. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF,. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006; 367 (9516): 1066-1074.
5. Callaghan WM, Kuklina EV, Berg CJ,. Trends in postpartum hemorrhage: United States, 1994-2006. Am J Obstet Gynecol. 2010; 202 (4): 353. e351-e356.
6. Joseph KS, Rouleau J, Kramer MS, et al. Investigation of an increase in postpartum haemorrhage in Canada. BJOG. 2007; 114 (6): 751-759.
7. Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth. 2009; 9: 55.
8. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013; 30 (6): 270-382.
9. Fuller AJ, Bucklin BA,. Blood product replacement for postpartum hemorrhage. Clin Obstet Gynecol. 2010; 53 (1): 196-208.
10. World Health Organization. WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage. Geneva: World Health Organization; 2012.
11. Royal College of Obstetricians Gynaecologists. Prevention and Management of Postpartum Haemorrhage. London, UK: Royal College of Obstetricians Gynaecologists; 2011.
12. Waterstone M, Bewley S, Wolfe C,. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ. 2001; 322 (7294): 1089-1093; discussion 1093-1084.
13. Wise A, Clark V,. Strategies to manage major obstetric haemorrhage. Curr Opin Anaesthesiol. 2008; 21 (3): 281-287.
14. Devine PC,. Obstetric hemorrhage. Semin Perinatol 2009; 33 (2): 76-81.
15. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007; 5 (1): 266-273.
16. Cortet M, Deneux-Tharaux C, Dupont C, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth. 2012; 108 (6): 984-989.
17. de Lloyd L, Bovington R, Kaye A, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth. 2011; 20 (2): 135-141.
18. Peyvandi F, Biguzzi E, Franchi F, et al. Elevated prepartum fibrinogen levels are not associated with a reduced risk of postpartum hemorrhage. J Thromb Haemost. 2012; 10 (7): 1451-1453.
19. Guasch E, Viejo A, Martínez B, et al. Hemorragia masiva obstétrica. Protocolo de actuación del Hospital Maternal Universitario La Paz. Act Anest Reanim (Madrid). 2006; 16 (2): 78-83.
20. Ducloy-Bouthors AS, Jude B, Duhamel A, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care. 2011; 15 (2): R117.
21. Novikova N, Hofmeyr GJ,. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2010;(7): CD007872.
22. Peitsidis P, Kadir RA,. Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum. Expert Opin Pharmacother. 2011; 12 (4): 503-516.
23. Shakur H, Elbourne D, Gulmezoglu M, et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials. 2010; 11: 40.
24. Bell SF, Rayment R, Collins PW, Collis RE,. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int J Obstet Anesth. 2010; 19 (2): 218-223.
25. Glover NJ, Collis RE, Collins P,. Fibrinogen concentrate use during major obstetric haemorrhage. Anaesthesia. 2010; 65 (12): 1229-1230.
26. Wikkelsoe AJ, Afshari A, Stensballe J, et al. The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial. Trials. 2012; 13: 110.
27. Annecke T, Geisenberger T, Kurzl R, Penning R, Heindl B,. Algorithm-based coagulation management of catastrophic amniotic fluid embolism. Blood Coagul Fibrinolysis. 2010; 21 (1): 95-100.
28. Sorensen B, Bevan D,. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol. 2010; 149 (6): 834-843.